These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ. Clin Infect Dis; 2008 Jan 15; 46(2):305-12. PubMed ID: 18171267 [Abstract] [Full Text] [Related]
9. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Moore RD, Keruly JC. Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456 [Abstract] [Full Text] [Related]
11. The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study. DeHovitz JA, Kovacs A, Feldman JG, Anastos K, Young M, Cohen M, Gange SJ, Melnick S, Greenblatt RM. J Infect Dis; 2000 Nov 01; 182(5):1527-30. PubMed ID: 11010840 [Abstract] [Full Text] [Related]
12. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Arch Intern Med; 2005 May 23; 165(10):1179-84. PubMed ID: 15911733 [Abstract] [Full Text] [Related]
19. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. López-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, Preston-Martin S, Anastos K. Am J Epidemiol; 2007 May 15; 165(10):1134-42. PubMed ID: 17339383 [Abstract] [Full Text] [Related]